Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Klinique Medical Clinic PCLBKK:KLINIQ 94 Debt-to-Equity is 0.35 as of Jun. 2026, which is at its 10-year median of 0.35. GuruFocus rates BKK:KLINIQ with a GF Score™ of 94/100 and a GF Value™ of ฿41.28 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 84 Personal Services companies, The Klinique Medical Clinic PCL ranks better than 60.71% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for The Klinique Medical Clinic PCL's Debt-to-Equity or its related term are showing as below:
BKK:KLINIQ'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03 Med: 0.35 Max: 1.91
Current: 0.35
During the past 7 years, the highest Debt-to-Equity Ratio of The Klinique Medical Clinic PCL was 1.91. The lowest was 0.03. And the median was 0.35.
BKK:KLINIQ's Debt-to-Equity is ranked better than 60.71% of 84
companies
in the Personal Services industry
Industry Median: 0.595
vs BKK:KLINIQ: 0.35
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
The Klinique Medical Clinic PCL Debt-to-Equity Related Terms
The Klinique Medical Clinic PCL Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Klinique Medical Clinic PCL Debt-to-Equity Chart
BKK:KLINIQ vs ROL, SCI, HRB: Debt-to-Equity Comparison
For the Personal Services subindustry, The Klinique Medical Clinic PCL's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Klinique Medical Clinic PCL Debt-to-Equity vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, The Klinique Medical Clinic PCL's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where The Klinique Medical Clinic PCL's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Klinique Medical Clinic PCL (BKK:KLINIQ) has a Debt-to-Equity of 0.35 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on The Klinique Medical Clinic PCL and its competitors. This is near median its historical median of 0.35. Over the past decade, The Klinique Medical Clinic PCL's Debt-to-Equity has ranged from 0.03 to 1.91. According to the industry distribution chart, The Klinique Medical Clinic PCL ranks #33 out of 84 companies in the Personal Services industry, placing it in the top 39.3%.
Is The Klinique Medical Clinic PCL's Debt-to-Equity too high?
The Klinique Medical Clinic PCL's current Debt-to-Equity of 0.35 is near median its 10-year median of 0.35. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 1.91. The Personal Services industry median Debt-to-Equity is 0.60. The Klinique Medical Clinic PCL's value of 0.35 is 41.2% below this industry median. Based on the distribution chart, The Klinique Medical Clinic PCL ranks #33 out of 84 companies in the Personal Services industry, which is above the industry midpoint. Overall, The Klinique Medical Clinic PCL has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Klinique Medical Clinic PCL's Debt-to-Equity compare to ROL and SCI?
According to the Personal Services industry distribution chart, The Klinique Medical Clinic PCL ranks #33 out of 84 companies for Debt-to-Equity. This puts The Klinique Medical Clinic PCL in the upper half of its industry. The industry median Debt-to-Equity is 0.60. The Klinique Medical Clinic PCL's value of 0.35 is 41.2% below this benchmark. Historically, The Klinique Medical Clinic PCL's own Debt-to-Equity has ranged from 0.03 to 1.91 over the past decade. While the company's 10-year median is 0.35 vs. the industry median of 0.60, The Klinique Medical Clinic PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Personal Services company?
The median Debt-to-Equity among Personal Services companies is 0.60, based on 84 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Klinique Medical Clinic PCL's current Debt-to-Equity of 0.35 is 41.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on The Klinique Medical Clinic PCL and its competitors. For the Personal Services industry, the median Debt-to-Equity is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Klinique Medical Clinic PCL's current Debt-to-Equity is 0.35, which is near median its own 10-year median of 0.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Klinique Medical Clinic PCL stock overvalued right now?
Based on GuruFocus' analysis, The Klinique Medical Clinic PCL (BKK:KLINIQ) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿41.28, compared to a current price of ฿31.25 — trading 24.3% below its estimated fair value. The current Debt-to-Equity is 0.35, which is near median its 10-year median of 0.35 and 41.2% below the Personal Services industry median of 0.60. The Klinique Medical Clinic PCL's overall GF Score™ is 94/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For The Klinique Medical Clinic PCL (BKK:KLINIQ), the current Debt-to-Equity is 0.35 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Klinique Medical Clinic PCL (BKK:KLINIQ) Overvalued in 2026?
Based on GuruFocus' analysis, The Klinique Medical Clinic PCL stock appears to be undervalued.
The current stock price of ฿31.25 is trading 24.3% below its estimated GF Value™ of ฿41.28.
GuruFocus considers The Klinique Medical Clinic PCL to be Modestly Undervalued.
Key valuation signals for BKK:KLINIQ:
Debt-to-Equity: 0.35 (near median its 10-year median of 0.35)
GF Value™: ฿41.28 vs. price of ฿31.25 (24.3% below fair value)
Industry Position: 41.2% below the Personal Services median (#33 of 84)
No single metric tells the full story. See the BKK:KLINIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Klinique Medical Clinic PCL provides skin care services, beauty, skin care, body contouring, and surgery. including providing holistic care services. The company has a wide range of services and products to meet the needs of customers at all levels, such as facial treatment services, reducing redness, reducing dark spots, laser services for face lifting, face reshaping, skin care, Body shape by removing and dissolving fat, cosmetic surgery, etc. In addition, the company also sells cosmeceuticals. There are various types of products, such as Special Care, Clean & Prepare, Whitening Set, Sun Care, and Antioxidant. The group operates two core business segments: Skin medical services and distribution of cosmetics and medical cosmetics; and Surgery services.
94GF Score
Get the complete analysis for BKK:KLINIQ
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:KLINIQ has been successfully added to your 
